Insider Shareholders with Direct Ownership of Keros Therapeutics, Inc. (KROS)
This section provides a comprehensive overview of the insiders with direct ownership of Keros Therapeutics, Inc. (KROS). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Keros Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Jasbir Seehra
CHIEF EXECUTIVE OFFICER |
148,867 | 0 | 392,723 $5.97 Million | 4 |
Sep 03, 2025
Added 18.73%
|
|
Jennifer Lachey
Chief Scientific Officer |
199,859 | 132,750 | 95,100 $1.44 Million | 44 |
Jul 15, 2022
Reduced 32.62%
|
|
Christopher Rovaldi
Chief Operating Officer |
62,592 | 2,592 | 60,000 $911,400 | 5 |
Feb 18, 2025
Added 50.0%
|
|
Keith Regnante
CHIEF FINANCIAL OFFICER |
124,000 | 80,000 | 44,000 $668,360 | 7 |
Feb 18, 2025
Added 50.0%
|
|
Yung H. Chyung
Chief Medical Officer |
44,000 | 0 | 44,000 $668,360 | 1 |
Feb 18, 2025
Added 50.0%
|
| 6,441 | 0 | 6,441 $97,838 | 2 |
Jun 04, 2025
Added 44.91%
|
|
| 5,250 | 0 | 5,450 $82,785 | 1 |
Jun 04, 2025
Added 49.07%
|
|
| 5,250 | 0 | 5,250 $79,747 | 1 |
Jun 04, 2025
Added 50.0%
|
|
| 5,250 | 0 | 5,250 $79,747 | 1 |
Jun 04, 2025
Added 50.0%
|
|
| 5,250 | 0 | 5,250 $79,747 | 1 |
Jun 04, 2025
Added 50.0%
|
|
| 5,250 | 0 | 5,250 $79,747 | 1 |
Jun 04, 2025
Added 50.0%
|
|
| 5,250 | 0 | 5,250 $79,747 | 1 |
Jun 04, 2025
Added 50.0%
|
|
| 5,250 | 0 | 5,250 $79,747 | 1 |
Jun 04, 2025
Added 50.0%
|
|
|
Claudia Ordonez
Chief Medical Officer |
5,000 | 5,000 | 0 $0 | 10 |
Jun 11, 2021
Reduced 100.0%
|